BridgeBio Pharma, Inc. (BBIO) Pre-Tax Margin
- 2026-06-30: Pre-Tax Margin -63.97%.
- 2025-12-31: Pre-Tax Margin -126.32%.
- 2025-09-30: Pre-Tax Margin -154.50%.
- 2025-06-30: Pre-Tax Margin -164.30%.
Complete source-backed pre-tax margin history.
- Available history
- 2019-12-31 to 2026-06-30
- Data captured
Historical Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|---|
| 2026-06-30 | -63.97% |
| 2025-12-31 | -126.32% |
| 2025-09-30 | -154.50% |
| 2025-06-30 | -164.30% |
| 2024-12-31 | -4526.28% |
| 2024-09-30 | -6012.23% |
| 2024-06-30 | -3484.50% |
Annual Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|---|
| 2025-12-31 | -145.89% |
| 2024-12-31 | -244.34% |
| 2023-12-31 | -7021.94% |
| 2022-12-31 | -624.17% |
| 2020-12-31 | 6127.87% |
| 2019-12-31 | 711.50% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |